Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Markus Radsak, MD, Steve Prüfer, PhD, Katharina Ebner, Michael Weber, PhD, Sebastian Reuter, PhD, Pamela Stein, PhD, Inge Scharrer, MD, Michael Stassen, PhD, Hansjörg Schild, PhD, Kerstin Jurk, PhD, Markus Bosmann, MD

Blood (2014) 124 (21): 4109.

https://doi.org/10.1182/blood.V124.21.4109.4109

Published: 2014

Journal Articles

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Sonja Alesci, MD, Mario Von Depka, Jennifer Feddern, Susan Halimeh, MD, Oliver Hegener, PhD, Janos Kadar, Wolfgang A. Miesbach, MD, PhD, Ulrike Nowak-Göttl, Inge Scharrer, MD, PhD

Blood (2013) 122 (21): 4775.

https://doi.org/10.1182/blood.V122.21.4775.4775

Published: 2013

Journal Articles

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Oliver Hegener, PhD, Inge Scharrer, MD, PhD, Jennifer Feddern, Wolfgang A. Miesbach V, MD, PhD, Mario Von Depka, Janos Kadar

Blood (2012) 120 (21): 4630.

https://doi.org/10.1182/blood.V120.21.4630.4630

Published: 2012

Journal Articles

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

Dennis K. Galanakis, MD, Miriam Rafailovich, Ph D, Tahmeena Ahmed, MD, Suphanne Pongkitwitoon, MS, Inge Scharrer, MD, PhD, Bohdan Kudryk, Ph D

Blood (2011) 118 (21): 2251.

https://doi.org/10.1182/blood.V118.21.2251.2251

Published: 2011

Journal Articles

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Mirjeta Qorraj, Tanja Falter, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3677.

https://doi.org/10.1182/blood.V116.21.3677.3677

Published: 2010

Journal Articles

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Tanja Falter, Mirjeta Qorraj, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3678.

https://doi.org/10.1182/blood.V116.21.3678.3678

Published: 2010

Journal Articles

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

Sarah Steinemann, Tanja Falter, Mirjeta Qorraj, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 4661.

https://doi.org/10.1182/blood.V116.21.4661.4661

Published: 2010

Journal Articles

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Vytautas Ivaskevicius, MD, Hannelore Rott, MD, Inge Scharrer, MD, PhD, Manuela Krause, MD, Erhard Seifried, MD, PhD, Johannes Oldenburg, MD, PhD

Blood (2007) 110 (11): 2150.

https://doi.org/10.1182/blood.V110.11.2150.2150

Published: 2007

Journal Articles

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Manuela Krause, MD, Christoph Koenigs, MD, Christoph Kessel, Inge Scharrer, MD, Ralf Grossmann, MD, Wolfhard Kreuz, MD

Blood (2006) 108 (11): 1044.

https://doi.org/10.1182/blood.V108.11.1044.1044

Published: 2006

Journal Articles

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Charis von Auer, MD, Kathrin Lotter, Sandra Heinsdorf, Inge Scharrer, MD

Blood (2006) 108 (11): 4075.

https://doi.org/10.1182/blood.V108.11.4075.4075

Published: 2006

Journal Articles

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Charis von Auer, MD, Sandra Heinsdorf, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2006) 108 (11): 4056.

https://doi.org/10.1182/blood.V108.11.4056.4056

Published: 2006

Journal Articles

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Inge Scharrer, MD, Martina Böhm, PhD

Blood (2005) 106 (11): 4027.

https://doi.org/10.1182/blood.V106.11.4027.4027

Published: 2005

Journal Articles

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Manuela Krause, MD, Charis von Auer, MD, Andreas Kurth, MD, Martina Boehm, MD, L. Hovy, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 4072.

https://doi.org/10.1182/blood.V106.11.4072.4072

Published: 2005

Journal Articles

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

Wolfgang A. Miesbach, MD, D. K. Galanakis, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 2138.

https://doi.org/10.1182/blood.V106.11.2138.2138

Published: 2005

Journal Articles

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Manuela Krause, MD, Anika Hahn, Ferrial Peyvandi, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 3981.

https://doi.org/10.1182/blood.V104.11.3981.3981

Published: 2004

Journal Articles

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Ulla Stumpf, MD, Andreas Kurth, MD, Steffen Bassus, MD, PhD, Thomas Scholz, Eng., Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 4029.

https://doi.org/10.1182/blood.V104.11.4029.4029

Published: 2004

Journal Articles

The Frequency and the Significance of ADAMTS-13 Neutralising Inhibitors in 62 Patients with Non-Familial Thrombotic Thrombocytopenic Purpura.

Martina Böhm, PhD, Manuela Krause, MD, Charis Von Auer, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 3945.

https://doi.org/10.1182/blood.V104.11.3945.3945

Published: 2004

Journal Articles

Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies.

Wolfgang A. Miesbach, MD, Geneth Asmelash, Birgit Puetz, Martina Boehm, PhD, Inge Scharrer, MD.

Blood (2004) 104 (11): 4039.

https://doi.org/10.1182/blood.V104.11.4039.4039

Published: 2004

Journal Articles

The Coinicidence of Venous and Arterial Thrombosis in Patients with Antiphospholipid Syndrome - Correlation with Laboratory Findings.

Wolfgang A. Miesbach, MD, Robert Hudeck, Martina Boehm, PhD, Inge Scharrer, MD.

Blood (2004) 104 (11): 4045.

https://doi.org/10.1182/blood.V104.11.4045.4045

Published: 2004

Journal Articles

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Steffen Bassus, MD, PhD, Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Thomas Scholz, Eng., Carmen Escuriola-Ettinghausen, MD, Annelie Siegemund, MD, Wolfhart Kreuz, MD, Lothar Engelmann, MD, Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 3098.

https://doi.org/10.1182/blood.V104.11.3098.3098

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

The Frequency and the Significance of ADAMTS-13 Neutralising Inhibitors in 62 Patients with Non-Familial Thrombotic Thrombocytopenic Purpura.

Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies.

The Coinicidence of Venous and Arterial Thrombosis in Patients with Antiphospholipid Syndrome - Correlation with Laboratory Findings.

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only